Algorithm study of DNA proves 90% accurate predicting bowel cancer

There is a new way to detect bowel cancer more than 90 % in predicting people with high risk that will develop the disease, according to research.

About 500,000 people live in the UK with IBD disease, including Crohn’s and ulcerative colitis.

Currently, regular tests for pre -cancer growth are provided in their intestine, which, if discovered, indicates a 30 % opportunity to develop bowel cancer over 10 years.

But UK research found that the changes in DNA in those cells previously for cancer, when analyzed by an algorithm, were more than 90 % minute to predict those who would develop bowel cancer over the next five years.

Researchers used IBD tissue samples – but it is hoped to use their way to develop a simple blood test to identify the most vulnerable IBD patients.

“Such research will save lives,” said Craig Foster, of Warlloville, whose wife, Variba, died due to bowel cancer in February 2024.

Farba has lived with ulcerative colitis since she was eighteen, when three quarters of the intestine were removed.

“It is for those who give me to know that there are scientists working at the present time so that no one must test the same position in which Variba was.”

“Farba died just six months after her injury was diagnosed.

“Although it was a short time, it was the worst time.

“Cancer does not take any prisoners – and it does not matter who you or from any walking in life, and everyone is affected in some way,”

“Most people with ulcerative colitis or Crohn’s disease will not have bowel cancer,” said Professor Trevor Graham, of the Cancer Research Institute in London.

But for those who have these conditions and show signs of pre -cancer in the colon, there are some difficult decisions that must be made.

“Either it was monitored regularly, hoping that it would not become cancer, or they removed the intestine to ensure that cancer is not infected in the future.

“Which of these options is particularly enjoyable.

“Our test and the algorithm of IBD, and the doctors who care about them, give the best possible information so that they can make the right decision on how to manage the risk of cancer.”

This was really positive news for those who suffer from conditions, “said Marian Radcliffe, of the Charity Foundation Crohn and the United Kingdom.

People tell us that one of the most difficult things to live with Crohn or colitis is uncertainty – in daily life and in the long run.

“As with inflammation of the bowel, we know that the more you discover early on cancer, the better.

“Anything enables early detection with faster and less distribution diagnostic tests, and remove some of this uncertainty, very exciting.”

Dr. Ian Volks, a UK’s cancer research, which funded the research, says progress in technology reshapes the understanding of diseases such as cancer.

“The genome sequence is now much cheaper and more widespread than ever – it changes how to look at cancer,” he said.

“Get a full reading of the tumor DNA means that we can see a much larger image of how a person’s cancer starts and how it is likely to change over time.

“Through this research, we can focus the resources on the treatment of people with IBD who are really at great risk, providing health services for valuable time and money.

“We can also give those who have peace of mind at a lower risk and remove the fear of future bowel cancer.”